Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi. [PDF]
Burke HM +7 more
europepmc +1 more source
Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries. [PDF]
Stout A +5 more
europepmc +1 more source
Development of a Client Experience of Care Metric to Measure Person-Centered Care for Injectable Contraceptive Clients in Lilongwe, Malawi. [PDF]
Felker-Kantor E +4 more
europepmc +1 more source
Erratum for: Odwe et al., Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]
europepmc +1 more source
Alleviating price and information barriers to long-acting contraception uptake in Kenyan pharmacies using patient and provider incentives: a cluster randomized control trial. [PDF]
Dieci M, Paramo C, Gertler PJ.
europepmc +1 more source
Determinants of contraceptive discontinuation among sexually active women in Nigeria: a systematic review. [PDF]
Afolabi A, Ilesanmi O, Akyala A.
europepmc +1 more source
Impacts of Contraception on Future Fertility: Addressing Concerns to Improve Understanding. [PDF]
Begg L, Owolabi O, Polis CB.
europepmc +1 more source
Barriers and Facilitators to Expanding User-Administered Injectable Contraceptives in the United States. [PDF]
Clark C, Cheng AL, Creason L, Karlin J.
europepmc +1 more source

